Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solecta is a membrane technology company that develops and manufactures polymeric membrane products, process equipment, and engineered separation systems for industrial end markets including life sciences. Its offerings span microfiltration, ultrafiltration, nanofiltration, and reverse osmosis membranes, supported by application engineering and consultative process optimization services. In life sciences, the company focuses on membrane-based separations used in bioprocessing and related production workflows rather than developing therapeutics. Solecta historically operated as a private company headquartered in Oceanside, California and built capabilities in membrane chemistry, element design, and manufacturing. In July 2025, Solecta merged with Nanostone Water to form Acuriant Technologies, and it now appears to operate as a brand/sub-organization within that combined company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solecta.